The biotech company has only one drug, Oxbryta, on the market, to treat sickle cell disease. Its shares were up Monday after falling on Friday.
Read More
Trade Forex like a professional with this excellent regulated broker
Learn About Cryptocurrencies
Keep Your Crypto Secure
